Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Debt / NOTE 0.599% 8/0
-
Market price (% of par)
-
98.54%
-
Total 13F principal
-
$483,301,000
-
Principal change
-
-$7,049,068
-
Total reported market value
-
$476,814,970
-
Number of holders
-
43
-
Value change
-
-$7,278,171
-
Number of buys
-
16
-
Number of sells
-
19
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 as of Q3 2019
As of 30 Sep 2019,
BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 was held by
43 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$483,301,000
in principal (par value) of the bond.
The largest 10 bondholders included
MACKAY SHIELDS LLC, ADVENT CAPITAL MANAGEMENT /DE/, Allianz Asset Management GmbH, LAZARD ASSET MANAGEMENT LLC, SHENKMAN CAPITAL MANAGEMENT INC, JPMORGAN CHASE & CO, STATE STREET CORP, Polar Capital LLP, BAKER BROS. ADVISORS LP, and AMERIPRISE FINANCIAL INC.
This page lists
43
institutional bondholders reporting positions
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.